+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DiamiR LLC - Product Pipeline Analysis, 2021 Update

  • PDF Icon

    Company Profile

  • 30 Pages
  • February 2022
  • GlobalData
  • ID: 4787291
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

DiamiR LLC (DiamiR) is a medical device company. The company is involved in the development and commercialization of technology based on analysis of brain-enriched microRNA biomarkers in blood plasma to be used for screening, early and differential diagnosis. It offers microRNAs that are a class of small non-coding regulatory RNA molecules, which modulate target gene expression and protein production. DiamiR offers universal screening test comprised of organ-enriched microRNA panels, which could be used to detect presence of pathology in a particular organ or organ system. The company develops programs for neurodegenerative diseases, healthy aging, and neurodevelopment disease. It has collaborations with academia, medical centers, disease foundations and industry. DiamiR is headquartered in Monmouth Junction, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company DiamiR LLC
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

DiamiR LLC Company Overview
  • DiamiR LLC Company Snapshot
  • DiamiR LLC Pipeline Products and Ongoing Clinical Trials Overview
  • DiamiR LLC - Pipeline Analysis Overview
  • DiamiR LLC - Key Facts
  • DiamiR LLC - Major Products and Services
  • DiamiR LLC Pipeline Products by Development Stage
  • DiamiR LLC Pipeline Products Overview
  • CogniMIR
  • CogniMIR Product Overview
  • Diagnostic Assay - Frontotemporal Degeneration
  • Diagnostic Assay - Frontotemporal Degeneration Product Overview
  • Diagnostic Assay - Rett Syndrome
  • Diagnostic Assay - Rett Syndrome Product Overview
  • Diagnostic Assay - Amyotropic Lateral Sclerosis
  • Diagnostic Assay - Amyotropic Lateral Sclerosis Product Overview
  • Diagnostic Assay - Parkinson's Disease
  • Diagnostic Assay - Parkinson's Disease Product Overview
  • Mdx Test - Brain Aging
  • Mdx Test - Brain Aging Product Overview
  • Mdx Test - MCI-AD Progression
  • Mdx Test - MCI-AD Progression Product Overview
  • Mdx Test - Mild Cognitive Impairment
  • Mdx Test - Mild Cognitive Impairment Product Overview
  • Universal Screening Test
  • Universal Screening Test Product Overview
  • DiamiR LLC - Key Competitors
  • DiamiR LLC - Key Employees
  • DiamiR LLC - Locations And Subsidiaries
  • Head Office

Recent Developments
  • DiamiR LLC, Recent Developments
  • Oct 05, 2020: DiamiR announces oral presentation at 21st International Conference on Alzheimer's Drug Discovery
  • Nov 20, 2019: DiamiR receives award from Alzheimer's Drug Discovery Foundation to accelerate development of microRNA biomarkers for Alzheimer's Disease
  • Sep 16, 2019: DiamiR announces additional $345,000 funding from the NIH for Development of CogniMIR
  • Jul 11, 2019: DiamiR announces publication of data on microRNA biomarkers for Rett Syndrome
  • Nov 05, 2018: DiamiR announces two publications on microRNA biomarkers and mechanisms of aging
  • Nov 05, 2018: DiamiR announces two publications on microRNA biomarkers and mechanisms of aging
  • Jul 19, 2018: DiamiR Announces Participation at 2018 Alzheimer's Association International Conference
  • Nov 14, 2017: DiamiR Announces Publication of Data on microRNA Biomarkers for Neurodegenerative Diseases in Alzheimer’s Research & Therapy
  • Mar 29, 2017: DiamiR Announces Oral Presentation at AD/PD 2017
  • Mar 15, 2017: DiamiR Awarded $2.75M Grant for Development of CogniMIR for Early Detection of Alzheimer's Disease

Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer

List of Tables
  • DiamiR LLC Pipeline Products and Ongoing Clinical Trials Overview
  • DiamiR LLC Pipeline Products by Equipment Type
  • DiamiR LLC Pipeline Products by Indication
  • DiamiR LLC, Key Facts
  • DiamiR LLC, Major Products and Services
  • DiamiR LLC Number of Pipeline Products by Development Stage
  • DiamiR LLC Pipeline Products Summary by Development Stage
  • CogniMIR - Product Status
  • CogniMIR - Product Description
  • Diagnostic Assay - Frontotemporal Degeneration - Product Status
  • Diagnostic Assay - Frontotemporal Degeneration - Product Description
  • Diagnostic Assay - Rett Syndrome - Product Status
  • Diagnostic Assay - Rett Syndrome - Product Description
  • Diagnostic Assay - Amyotropic Lateral Sclerosis - Product Status
  • Diagnostic Assay - Amyotropic Lateral Sclerosis - Product Description
  • Diagnostic Assay - Parkinson's Disease - Product Status
  • Diagnostic Assay - Parkinson's Disease - Product Description
  • Mdx Test - Brain Aging - Product Status
  • Mdx Test - Brain Aging - Product Description
  • Mdx Test - MCI-AD Progression - Product Status
  • Mdx Test - MCI-AD Progression - Product Description
  • Mdx Test - Mild Cognitive Impairment - Product Status
  • Mdx Test - Mild Cognitive Impairment - Product Description
  • Universal Screening Test - Product Status
  • Universal Screening Test - Product Description
  • DiamiR LLC, Key Employees
  • Glossary

List of Figures
  • DiamiR LLC Pipeline Products by Equipment Type
  • DiamiR LLC Pipeline Products by Development Stage

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Biognosys Inc
  • Abcam Inc
  • Exiqon Diagnostics, Inc.